KemPharm’s KP415 and Serdexmethylphenidate (SDX) Prodrug to be Featured in Multiple Sessions at the AACAP 2020 Virtual Meeting - Seite 4

Nachrichtenquelle: globenewswire
22.10.2020, 13:30  |  111   |  0   |   

Diesen Artikel teilen
Seite 4 von 3
Wertpapier


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

KemPharm’s KP415 and Serdexmethylphenidate (SDX) Prodrug to be Featured in Multiple Sessions at the AACAP 2020 Virtual Meeting - Seite 4 CELEBRATION, Fla., Oct. 22, 2020 (GLOBE NEWSWIRE) - KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced that research involving KP415 and …

Community

Nachrichten des Autors

Titel
Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in ...
BIGG Digital Assets Inc. Announces Grant of Stock Options
Relay Acquires IoT Cybersecurity Firm Cybeats Technologies Fortifying Critical Pandemic Device ...
CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis ...
AMD Unveils AMD Radeon RX 6700 XT Graphics Card, Delivering Exceptional 1440p PC Gaming ...
Monument veröffentlicht Finanzergebnisse des zweiten Quartals 2021 („Q2 2021“)
Clean Power Capital Corp.: PowerTap applauds California city for banning new gas stations
Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as ...
Castor Maritime Inc. Announces Delivery of the M/V Magic Venus and New Charter Agreement
Titel
Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results ...
Orocobre Limited Reports H1 FY21 Results
SeaBird Exploration Plc: Information relating to the distribution of shares in Green Minerals AS
Bitfarms Announces Purchase Agreement for 48,000 MicroBT Miners to Expand Hash Rate Capacity by ...
Algernon Pharmaceuticals Announces Private Placement
Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in ...
Hunter Technology Market Testing Pilot April Launch
3D Systems Reports Fourth Quarter and Full Year 2020 Financial Results (Unaudited), Reschedules ...
Die Aktionäre von Novartis heissen an der Generalversammlung alle Anträge des Verwaltungsrats gut
BIGG Digital Assets Inc. Announces Grant of Stock Options
Titel
Spineway Expansion in Asia
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of ...
Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to ...
SPINEWAY: NEW BUSINESS AGREEMENT DEDICATED TO 3D INNOVATION
American Lithium Reaches Agreement to Acquire Plateau Energy Metals and Consolidate ...
REPEAT --TAAT E-Commerce Launching Wednesday February 17, Availing Original, Smooth, and Menthol to ...
Emerging Markets Report: One + One = Three
Ocugen, Inc. Announces Closing of $23 Million Registered Direct Offering of Common Stock
EHang Responds to Deceptive Wolfpack Research Report
Seeking Alpha Blog Post Details Growth of Alternatives to Incumbent CPG Products in February 11 ...
Titel
Spineway Expansion in Asia
AgraFlora Organics Expects to Enter Edibles Market in Q1
HyperSolar Changes Company Name to SunHydrogen
Halo Announces Pricing of Overnight Marketed Offering of Units
WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020
Bombardier unterzeichnet Vertrag für weitere zehn Jahre Betrieb und Wartung des automatischen ...
Ocugen and Bharat Biotech to Co-Develop COVAXIN, a Whole-Virion Inactivated COVID-19 Vaccine, for ...
HyperSolar To Begin Production on 100 Hydrogen Generation Units for Demonstration
Mateon Expands its COVID-19 Therapeutic Program to include Artemisinin
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of ...

Nachrichten zu den Werten

ZeitTitel
03.03.21
KemPharm Announces FDA Approval of AZSTARYS (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII), A New Once-Daily Treatment for ADHD

COMMUNITY

ZeitTitel
27.08.20
4
KMPH Marktcap 12M$ PDUFA am 02.03.2021